Ulrike Seitz
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
-
- Medicinal Plant Extracts Effects
Papers in
-
- Radiopharmaceutical Chemistry and Applications 4
- Medical Imaging Techniques and Applications 3
- Oncology 3
- Lung Cancer Research Studies 1
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Sven N. Reske (7 shared papers)Bernd Neumaier (5 shared papers)Gerhard Glatting (6 shared papers)Andreas K. Buck (4 shared papers)Donald Bunjes (4 shared papers)Gerd Munzert (2 shared papers)Edgar Wawra (2 shared papers)Johannes Gleitz (1 shared paper)
In The Last Decade
Ulrike Seitz
10 papers receiving 496 citations
Peers
Comparison fields: 5 of 65
- Radiology, Nuclear Medicine and Imaging 255
- Complementary and alternative medicine 42
- Hematology 56
- Pharmacology 39
- Pathology and Forensic Medicine 69
Countries citing papers authored by Ulrike Seitz
This map shows the geographic impact of Ulrike Seitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Seitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Seitz more than expected).
Fields of papers citing papers by Ulrike Seitz
This network shows the impact of papers produced by Ulrike Seitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Seitz. The network helps show where Ulrike Seitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulrike Seitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease. | 2003 | 136 |
| 2 | 2001 | 126 | |
| 3 | 2002 | 55 | |
| 4 | 1997 | 50 | |
| 5 | 1999 | 44 | |
| 6 | 2002 | 30 | |
| 7 | 2001 | 25 | |
| 8 | 1998 | 25 | |
| 9 | In vivo evaluation of 5-[(18)F]fluoro-2'-deoxyuridine as tracer for positron emission tomography in a murine pancreatic cancer model. | 2001 | 14 |
| 10 | 1998 | 7 |
About Ulrike Seitz
Ulrike Seitz is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pharmacology, Organic Chemistry and Molecular Biology, having authored 10 papers that have together received 512 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (4 papers), Medical Imaging Techniques and Applications (3 papers), Alkaloids: synthesis and pharmacology (2 papers), Plant-based Medicinal Research (2 papers), Acute Myeloid Leukemia Research (1 paper), Lung Cancer Research Studies (1 paper), Advanced Radiotherapy Techniques (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (255 citations), Complementary and alternative medicine (42 citations), Hematology (56 citations), Pharmacology (39 citations) and Pathology and Forensic Medicine (69 citations). Ulrike Seitz has collaborated with scholars based in Germany and Austria. Frequent co-authors include Sven N. Reske, Bernd Neumaier, Gerhard Glatting, Andreas K. Buck, Donald Bunjes, Gerd Munzert, Edgar Wawra, Johannes Gleitz, Angela Ameri and Hartmut Döhner. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Cancer Biotherapy and Radiopharmaceuticals, Biochemical Pharmacology, Experimental Brain Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.